OrSense, a medical device company, has presented its new non-invasive hemoglobin (Hb) monitor on the World Blood Donors Day. The monitor has the potential of attracting and retaining more blood donors.
According to Dr. Emma Castro, who is the CEO of the Transfusion Center of the Spanish Red Cross in Madrid, both donors and staff were eagerly waiting for a non-invasive system for measuring pre-donation Hb. Their donors are happy about implementing the OrSense system and it is expected that this system could be used as a tool for enlarging the blood donor community. Most donors find pricking the finger painful and uncomfortable and hence this new system would help alter what is normally a deterring experience to a pleasant one.
OrSense’s CEO, Lior Ma’ayan revealed that their non-invasive Hb monitor would enhance staff and donor safety with its simple easy-to-use operation. Everybody gains from this system as donors would experience a lot of comfort and hence will increase recruitment of blood donors and also encourage first time donors for blood donation.
During the National Congress of SETS, which is the Spanish transfusion society, to be held from June 15 to 17, 2011 in Malaga in Spain, Dr. Castro would be giving an oral presentation, wherein she would discuss the OrSense non-invasive monitor. She along with her team would demonstrate the OrSense device and compare it with other invasive techniques.
Dr. R.N. Makroo from the Indraprastha Apollo Hospital in Delhi, India would also be presenting his results on non-invasive Hb at the Regional Conference of ISRT, which would be conducted from June 18 to 22, 2011 in Lisbon, Portugal. Aharon Weinstein from OrSense along with Professor A. Kornberg from Assaf Harofeh Medical Center’s Department of Hematology and Blood Bank in Israel will give a presentation at the ISBT.
During the Euroanesthesia 2011 conference conducted by the Europeans Society of anesthesia, in Amsterdam, the OrSense non-invasive Hb monitor’s performance was demonstrated and talked about by Professor. P. Singer of the General ICU Rabin Medical Center in Israel, along with Aharon Weinstein from OrSense. This device could precisely detect rapid changes in Hb levels and at the same time maintain dependability even at very low levels of Hb blood content. It functions by using a ring-shaped sensor, which would be fixed on the donor’s finger. Pressure would be applied which would lead to a temporary occlusion of blood flow. This method known as Occlusion Spectroscopy gives the medical staff accurate and immediate results and at the same time dramatically improves the donor’s comfort and eliminates the risk of infection.
Source: http://www.orsense.com